![]() |
Gefitinib-Induced Interstitial Lung Disease in Korean Lung Cancer Patients
Seung-Hoon Beom, Dong-Wan Kim, Sung Hoon Sim, Bhumsuk Keam, Jin Hyun Park, Jeong-Ok Lee, Tae Min Kim, Se-Hoon Lee, Dae Seog Heo
Cancer Res Treat. 2016;48(1):88-97. Published online 2015 Mar 3 DOI: https://doi.org/10.4143/crt.2014.201
|
Citations to this article as recorded by
Osimertinib for Japanese patients with T790M‐positive advanced non‐small‐cell lung cancer: A pooled subgroup analysis
Tomonori Hirashima, Miyako Satouchi, Toyoaki Hida, Makoto Nishio, Terufumi Kato, Hiroshi Sakai, Fumio Imamura, Katsuyuki Kiura, Isamu Okamoto, Kazuo Kasahara, Hirohiko Uchida, Sarah L. Vowler, Tetsuya Mitsudomi
Cancer Science.2019; 110(9): 2884. CrossRef Ethnic differences in idiopathic pulmonary fibrosis: The Japanese perspective
Shigeki Saito, Joseph A. Lasky, Koichi Hagiwara, Yasuhiro Kondoh
Respiratory Investigation.2018; 56(5): 375. CrossRef Personalized chemotherapy of lung cancer: What the radiologist should know
G.R. Ferretti, E. Reymond, A. Delouche, L. Sakhri, A. Jankowski, D. Moro-Sibilot, S. Lantuejoul, A.C. Toffart
Diagnostic and Interventional Imaging.2016; 97(3): 287. CrossRef Tyrosine Kinase Inhibitor-Induced Interstitial Lung Disease: Clinical Features, Diagnostic Challenges, and Therapeutic Dilemmas
Rashmi R. Shah
Drug Safety.2016; 39(11): 1073. CrossRef Combination Therapy of Gefitinib and Korean Herbal Medicines Could be a Beneficial Option for Patients with Non-Small-Cell Lung Cancer
Namhun Lee, Kangwook Lee, Yoon-sik Kim, Chang-Gue Son, Jung-Hyo Cho, Hwa-Seung Yoo, Jonghoon Lee, Juyoung Ryu
Journal of Pharmacopuncture.2016; 19(3): 259. CrossRef Imagerie du suivi post-thérapeutique des traitements personnalisés systémiques du cancer bronchique
G. Ferretti, E. Reymond, J. Cohen, A. Jankowski, M. Giaj-Levra, A.C. Toffart, D. Moro-Sibilot
Revue des Maladies Respiratoires Actualités.2016; 8(5): 325. CrossRef
|